Congrats to the Vividion team on a KEAP1 binder which unexpectedly turned out to be a KEAP1/CUL3 molecular glue to degrade NRF2. Unexpected activity since known binders inhibit KEAP1 rather than activate. Kudos to sticking with the data and expecting the unexpected! link below
Latest posts 5
I have benefited greatly from some amazing books that helped define my approach to science, startups and leadership. Delighted to pass them on! 1/5
In what started as a control experiment we were surprised to find transcriptional heterogeneity even in cancer cell lines, in ways that make certain subpopulations resistant to standard of care tx. nature.com/articles/s4159…
Its been thrilling to see Rezo hitting its stride in mapping networks, prosecuting targets and drilling into drug discovery. Amazing things to come. We are excited to build the NextGen Sequence->Systems->Structures->Drugs platform!
Rezo is excited to be included among @biospace's NextGen Class of 2024! 2023 was an important year for Rezo and we look forward to carrying that same momentum into the new year as we seek to unlock a new era of #drugdiscovery. biospace.com/article/nextge…View quoted post on X
Great department and wonderful place to start your career!